Physician profile
Anthony Bavry
NPI 1710157714
$75,547.08
in general payments reported to CMS, 2019-2025
10 companies · $2,806 in 2025
The $2,806 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $139 · 2021: $184 · 2022: $3,210 · 2023: $28K · 2024: $11K · 2025: $2,806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Travel and Lodging: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Food and Beverage: $4,393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,865.00 |
| Travel and Lodging | $10,533.89 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Food and Beverage | $4,393.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $70,723.56 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $3,816.96 | 2019-2025 | Mitraclip, Ultreon, Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic, INC. | $351.64 | 2022-2025 | Corevalve Evolut R |
| Medtronic Vascular, INC. | $288.14 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $172.47 | 2025 | Gore Cardioform Asd Occluder |
| Abiomed | $114.98 | 2025 | |
| Angiodynamics, INC. | $43.64 | 2025 | Alphavac |
| Stimwave Technologies Incorporated | $22.00 | 2019 | |
| Asahi Intecc USA, INC. | $13.69 | 2024 | Peripheral Vascular |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Bavry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.